Post the two acquisitions, target price updates: CCZ Equities 58c (up from 53c) Cannacord 55c (up from 54c) FY15 EBITDA estimated at $15.7m trading on 12x FY15 EBITDA
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025